annual EBITDA:
-$109.63M+$118.17M(+51.88%)Summary
- As of today (June 1, 2025), ARQT annual EBITDA is -$109.63 million, with the most recent change of +$118.17 million (+51.88%) on December 31, 2024.
- During the last 3 years, ARQT annual EBITDA has risen by +$96.28 million (+46.76%).
- ARQT annual EBITDA is now -2569.87% below its all-time high of -$4.11 million, reached on December 31, 2017.
Performance
ARQT EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$18.67M-$14.21M(-318.92%)Summary
- As of today (June 1, 2025), ARQT quarterly EBITDA is -$18.67 million, with the most recent change of -$14.21 million (-318.92%) on March 31, 2025.
- Over the past year, ARQT quarterly EBITDA has increased by +$8.55 million (+31.42%).
- ARQT quarterly EBITDA is now -318.92% below its all-time high of -$4.46 million, reached on December 31, 2024.
Performance
ARQT quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$101.07M+$8.55M(+7.80%)Summary
- As of today (June 1, 2025), ARQT TTM EBITDA is -$101.07 million, with the most recent change of +$8.55 million (+7.80%) on March 31, 2025.
- Over the past year, ARQT TTM EBITDA has increased by +$81.31 million (+44.58%).
- ARQT TTM EBITDA is now -1597.83% below its all-time high of -$5.95 million, reached on December 31, 2018.
Performance
ARQT TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ARQT EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +51.9% | +31.4% | +44.6% |
| 3 y3 years | +46.8% | +70.0% | +56.5% |
| 5 y5 years | -154.6% | +34.8% | -56.1% |
ARQT EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +62.8% | -318.9% | +81.8% | at high | +66.9% |
| 5 y | 5-year | -154.6% | +62.8% | -318.9% | +81.8% | -56.1% | +66.9% |
| alltime | all time | -2569.9% | +62.8% | -318.9% | +81.8% | -1597.8% | +66.9% |
ARQT EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$18.67M(+318.9%) | -$101.07M(-7.8%) |
| Dec 2024 | -$109.63M(-51.9%) | -$4.46M(-86.7%) | -$109.63M(-32.9%) |
| Sep 2024 | - | -$33.45M(-24.8%) | -$163.28M(-0.2%) |
| Jun 2024 | - | -$44.50M(+63.5%) | -$163.63M(-10.3%) |
| Mar 2024 | - | -$27.22M(-53.2%) | -$182.38M(-20.0%) |
| Dec 2023 | -$227.79M(-22.7%) | -$58.11M(+71.9%) | -$227.86M(-2.8%) |
| Sep 2023 | - | -$33.80M(-46.6%) | -$234.50M(-22.7%) |
| Jun 2023 | - | -$63.26M(-13.0%) | -$303.24M(-0.7%) |
| Mar 2023 | - | -$72.69M(+12.3%) | -$305.23M(+3.5%) |
| Dec 2022 | -$294.87M(+43.2%) | -$64.76M(-36.8%) | -$294.87M(-2.1%) |
| Sep 2022 | - | -$102.53M(+57.1%) | -$301.31M(+17.9%) |
| Jun 2022 | - | -$65.25M(+4.7%) | -$255.64M(+10.1%) |
| Mar 2022 | - | -$62.34M(-12.4%) | -$232.29M(+12.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$205.90M(+51.9%) | -$71.19M(+25.2%) | -$205.90M(+22.7%) |
| Sep 2021 | - | -$56.86M(+35.7%) | -$167.77M(+12.5%) |
| Jun 2021 | - | -$41.90M(+16.6%) | -$149.18M(+4.4%) |
| Mar 2021 | - | -$35.94M(+8.7%) | -$142.88M(+5.4%) |
| Dec 2020 | -$135.56M(+214.8%) | -$33.06M(-13.6%) | -$135.56M(+17.4%) |
| Sep 2020 | - | -$38.27M(+7.5%) | -$115.46M(+25.8%) |
| Jun 2020 | - | -$35.60M(+24.4%) | -$91.82M(+41.8%) |
| Mar 2020 | - | -$28.62M(+120.7%) | -$64.76M(+50.4%) |
| Dec 2019 | -$43.06M(+118.2%) | -$12.97M(-11.3%) | -$43.06M(+19.5%) |
| Sep 2019 | - | -$14.63M(+71.4%) | -$36.05M(+68.3%) |
| Jun 2019 | - | -$8.54M(+23.2%) | -$21.42M(+66.3%) |
| Mar 2019 | - | -$6.93M(+16.4%) | -$12.88M(+116.4%) |
| Dec 2018 | -$19.73M(+380.6%) | -$5.95M | -$5.95M |
| Dec 2017 | -$4.11M | - | - |
FAQ
- What is Arcutis Biotherapeutics annual EBITDA?
- What is the all time high annual EBITDA for Arcutis Biotherapeutics?
- What is Arcutis Biotherapeutics annual EBITDA year-on-year change?
- What is Arcutis Biotherapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Arcutis Biotherapeutics?
- What is Arcutis Biotherapeutics quarterly EBITDA year-on-year change?
- What is Arcutis Biotherapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Arcutis Biotherapeutics?
- What is Arcutis Biotherapeutics TTM EBITDA year-on-year change?
What is Arcutis Biotherapeutics annual EBITDA?
The current annual EBITDA of ARQT is -$109.63M
What is the all time high annual EBITDA for Arcutis Biotherapeutics?
Arcutis Biotherapeutics all-time high annual EBITDA is -$4.11M
What is Arcutis Biotherapeutics annual EBITDA year-on-year change?
Over the past year, ARQT annual EBITDA has changed by +$118.17M (+51.88%)
What is Arcutis Biotherapeutics quarterly EBITDA?
The current quarterly EBITDA of ARQT is -$18.67M
What is the all time high quarterly EBITDA for Arcutis Biotherapeutics?
Arcutis Biotherapeutics all-time high quarterly EBITDA is -$4.46M
What is Arcutis Biotherapeutics quarterly EBITDA year-on-year change?
Over the past year, ARQT quarterly EBITDA has changed by +$8.55M (+31.42%)
What is Arcutis Biotherapeutics TTM EBITDA?
The current TTM EBITDA of ARQT is -$101.07M
What is the all time high TTM EBITDA for Arcutis Biotherapeutics?
Arcutis Biotherapeutics all-time high TTM EBITDA is -$5.95M
What is Arcutis Biotherapeutics TTM EBITDA year-on-year change?
Over the past year, ARQT TTM EBITDA has changed by +$81.31M (+44.58%)